Plain-English translation of NCT07072624 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After a severe head injury, some patients develop seizures weeks or months later. This trial is testing whether giving or — two medications commonly used to prevent seizures — immediately after a serious brain injury can stop these seizures from happening. The study will also look at whether a person's genes affect how well these medications work.
Doctors are not sure which seizure prevention medication (if any) works best after traumatic brain injury, or whether giving medication early really makes a difference. This trial will provide clear evidence to help guide treatment decisions and may show how genetic differences between people affect whether these medications are safe and effective.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either , , or a placebo (inactive pill) as a preventive treatment. You will also provide a blood sample so researchers can look at your genes and see how they might affect how your body handles the medication. The study team will track whether you develop seizures, monitor your recovery, and assess how well you're doing over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
India